11. Human herpesvirus-encoded MicroRNA in host-pathogen interaction. (December 2021) Authors: Valverde, Araceli; Seal, Alexandra; Nares, Salvador; Shukla, Deepak; Naqvi, Afsar Raza Journal: Advances in biological regulation Issue: Volume 82(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Inhibition of Myosin Light Chain Kinase Can be Targeted for the Development of New Therapies against Herpes Simplex Virus Type-1 Infection. Issue 1 (January 2014) Authors: Antoine, Thessicar E; Shukla, Deepak Journal: Antiviral therapy Issue: Volume 19:Issue 1(2014) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Nonprofessional Phagocytosis Can Facilitate Herpesvirus Entry into Ocular Cells. (15th March 2012) Authors: Tiwari, Vaibhav; Shukla, Deepak Other Names: Chentoufi Aziz Alami Academic Editor. Journal: Clinical & developmental immunology Issue: Volume 2012(2012) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Optineurin in ocular herpes infection. (June 2022) Authors: Grinage, Earon; Shukla, Deepak Journal: Experimental eye research Issue: Volume 219(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. OPTN (optineurin)-mediated selective autophagy prevents neurodegeneration due to herpesvirus infection. Issue 4 (3rd April 2022) Authors: Patil, Chandrashekhar D.; Shukla, Deepak Journal: Autophagy Issue: Volume 18:Issue 4(2022) Page Start: 944 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Pathobiology and treatment of viral keratitis. (April 2021) Authors: Koganti, Raghuram; Yadavalli, Tejabhiram; Naqvi, Raza Ali; Shukla, Deepak; Naqvi, Afsar R. Journal: Experimental eye research Issue: Volume 205(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. SARS‐CoV‐2 targeting by RNAi and host complement inhibition: A two‐pronged subterfuge for COVID‐19 treatment. Issue 1 (13th October 2021) Authors: Naqvi, Raza Ali; Shukla, Deepak; Naqvi, Afsar R. Journal: Immunity, inflammation and disease Issue: Volume 10:Issue 1(2022) Page Start: 22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. The utility of the Edinburgh Depression Scale as a screening tool for depression in Parkinson's disease. (15th April 2014) Authors: Baillon, Sarah; Lindesay, James; Prabhakaran, Pravin; Hands, Oli; Murray, Jonathan; Stacey, Suzanne; Gaur, Sandhya; Rajkonwar, Aniruddha; Padmanabhan, Jayaraj; Shukla, Deepak; Chakrabarti, Santanu; Lo, Nelson; Dennis, Michael Journal: International journal of geriatric psychiatry Issue: Volume 29:Number 12(2014:Dec.) Page Start: 1286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Unraveling the cell entry mechanisms of HSV: therapeutic potential?. (May 2012) Authors: Shukla, Deepak Journal: Future virology Issue: Volume 7:Number 5(2012) Page Start: 427 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗